WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 1002
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 1462

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 69'360  67'514  65'705  63'932  62'191  46'949  34'911  26'357 
Births 2'938  2'889  2'839  2'790  2'741  2'255  1'710  1'228 
Surviving infants 2'625  2'577  2'529  2'481  2'433  1'973  1'505  1'072 
Pop. less than 5 years 12'122  11'907  11'691  11'455  11'180  8'844  6'566  4'780 
Pop. less than 15 years 31'072  30'400  29'712  29'006  28'275  21'807  15'894  11'755 
Female 15-49 years 15'985  15'488  15'011  14'556  14'125  10'370  7'857  6'099 

Number of reported case

(Click for retrospective incidence data for Democratic Republic of the Congo (the))
Diphtheria 43 
Japanese encephalitis
Measles 33'711  88'381  72'029  133'802  5'407  8'282  4'564  32'596 
Mumps
Pertussis 3'407  2'452  2'157  75  15'335 
Polio* 17  104  118  603  263 
Rubella 864  1'704  1'860  318  130 
Rubella (CRS)
Tetanus (neonatal) 201  1'252  888  990  77  120 
Tetanus (total)** 201  1'296  943  1'038  77  848 
Yellow fever 195  289 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Democratic Republic of the Congo (the))
Vaccine year result method % card seen                                                
BCG 2012  83  DHS   26  90  95  88  77  96  57 
DTP1 2012  81  DHS   26  99  97  99  98  87  49 
DTP3 2012  61  DHS   26  93  87  89  90  78  40 
HepB_BD         
HepB3 2012  61  DHS   26  93  87  89  90  78 
Hib3 2012  61  DHS   26  93  87  89  90  78 
JapEnc         
MCV          89  88  84  85  87  46 
MCV2         
PCV1          86  64  34  18 
PCV3          74  44  27 
Pol3 2012  66  DHS   26  92  87  89  90  88  42 
Rota1         
Rota_last         
Rubella1         
TT2plus 1994  33  MICS   30  88  85  86  84  85  25 
PAB         
VAD1          91  99*  99*  85 
YFV 2012  65  DHS   26  76  75  76  63  82 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Democratic Republic of the Congo (the))
BCG 78  78  67  86  57  65  57 
DTP1 86  86  85  71  49  60 
DTP3 72  72  74  60  40  35 
HepB3 72  72  74  60 
HepB_BD
Hib3 72  72  74  60 
MCV 73  73  74  74  46  38  18 
MCV2
PAB 75  70  70  77  45  53 
PCV3 26  26 
Pol3 76  76  77  76  42  34  15 
Rota_last
YFV 61  61  48  67 

Number of districts in the country 516  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 62
From 80 to 89% 22
From 50 to 79% 14
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV From April 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus From January 2016
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, +6 months; Yes every 6 months until 59 months
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2015  2013-2015  2013-2015  2011-2015  2008-2012  2008-2012  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 514  514  509  235  205  338 

System performance

Total Nº districts in country number 516  516  513  509  508  508  515 
Nº districts with DTP3 coverage >=80% number 430  414  399  353  246  396  278 
% of districts with DTP3 coverage >=80% From 0 to 100% 83  80  78  69  48  78  54 
Nº districts with measles (MCV1) coverage >=95% number 185  137  196  145  147  142  83 
% of districts with MCV1 coverage >=95% From 0 to 100% 36  27  38  28  29  28  16 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 31 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.